|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mechanisms of Hormone Action |
Unité d'Endocrinologie Moléculaire,3 Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas Cedex, France
Gene Expression and Development,4 Roslin Institute, Midlothian EH25 9PS, United Kingdom
Prolactin (PRL) initiates signal transduction by inducing homodimerization of PRL receptor (PRL-R). We have previously developed a mutant form of the PRL-R in which a part of the extracellular domain is deleted. This receptor constitutively activates protein gene transcription. We examined the oligomerization of the mutant PRL-R using two differently epitope-tagged receptors in a coimmunoprecipitation assay. It was shown that mutant receptor dimers were formed in a ligand-independent manner, which may explain the constitutive activity on milk protein gene expression. To study the biological activity of this mutant PRL-R on mammary gland development, we generated two lines of transgenic mice expressing the corresponding cDNA specifically in the mammary epithelial cells. For both transgenic lines, the mammary gland of 8-wk-old virgin mice was overdeveloped with numerous dilated ductal and alveolar structures, whereas only a limited duct network was present in wild-type animals at the same age. During pregnancy, the ducts and alveoli of transgenic mice were more developed than those of control animals. At parturition, the transgenic animals failed to lactate and nourish their offspring, and the involution of the mammary gland was strongly delayed. In conclusion, the expression of a constitutively active PRL-R by transgenesis induces a premature and abnormal mammary development and impairs terminal differentiation and milk production at the end of pregnancy.
2 Correspondence: Isabelle Gourdou, Unité d'Endocrinologie Moléculaire, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas Cedex, France. FAX: 0033 1 3465 2241; gourdou{at}jouy.inra.fr
This article has been cited by other articles:
![]() |
R. L. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan, J.-B. Jomain, A. Bachelot, F. Kuttenn, P. A. Kelly, V. Goffin, et al. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors PNAS, September 23, 2008; 105(38): 14533 - 14538. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manhes, C. Kayser, P. Bertheau, B. Kelder, J. J Kopchick, P. A Kelly, P. Touraine, and V. Goffin Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. J. Endocrinol., August 1, 2006; 190(2): 271 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Farmer and M.-F. Palin Exogenous prolactin stimulates mammary development and alters expression of prolactin-related genes in prepubertal gilts J Anim Sci, April 1, 2005; 83(4): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, and S. Y. Fuchs Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF{beta}-TrCP E3 Ubiquitin Ligase Mol. Cell. Biol., May 1, 2004; 24(9): 4038 - 4048. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |